MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BTMD — Biote Corp. Class A Common Stock

Nasdaq

Biote Corp. Class A Common Stock

CompareBack to Screener
$1.15
-0.01(-0.86%)
O
1.16
H
1.23
L
1.15
V
90.37K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About BTMD

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS
SectorNot available
IPO DateMay 27, 2022
Employees223
Stock ExchangeNasdaq
Ticker SymbolBTMD

Key Financial Statistics

Market Cap$34.99M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$1.15 - $3.26
52-Week Avg Volume217.8K
VWAP$1.18
Transactions1,260
Total Recorded Bars1,312 days